PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT (PLM) CHECKLIST 2026

Created by ChecklistGuro (https://checklistguro.com)


--- PRODUCT DEVELOPMENT & R&D DOCUMENTATION ---
[ ] Formulation Development Completion Date
[ ] Development Stage (Pre-clinical, Clinical Phase I/II/III, Registration/NDA, Commercialization)
[ ] Required Stability Studies Completed (Accelerated Stability, Long-term Stability, Stress Testing, Photostability)
[ ] Upload Formulation Master Record
[ ] Summary of Key R&D Deviations
[ ] R&D Lead Verification Signature

--- TECHNOLOGY TRANSFER & SCALE-UP VERIFICATION ---
[ ] Transfer Start Date
[ ] Transfer Type (R&D to Pilot Scale, Pilot Scale to Commercial, Site-to-Site Transfer, Post-Approval Change)
[ ] Originating Facility/Lab ID
[ ] Scale-Up Critical Parameters Verified (Mixing/Agitation Speed, Temperature Profiles, Pressure Settings, Addition/Dosing Rates, Filtration/Centrifugation Parameters)
[ ] Gap Analysis Summary
[ ] Scale-Up Protocol Document
[ ] Technical Lead Approval

--- REGULATORY SUBMISSION & REGISTRATION COMPLIANCE ---
[ ] Submission Date
[ ] Regulatory Body Name
[ ] Submission Type (New Drug Application (NDA), Abbreviated New Drug Application (ANDA), Supplement/Variation, Annual Report)
[ ] Required Documentation Verified (CMC Documentation, Stability Data Reports, Clinical Study Reports, Manufacturing Site Licenses, Labeling and Package Insert Drafts)
[ ] Final Dossier Draft
[ ] Regulatory Affairs Lead Approval

--- COMMERCIAL MANUFACTURING & PROCESS CONTROL ---
[ ] Batch Manufacturing Date
[ ] Batch/Lot Number
[ ] Production Line Identification (Line A - Sterile, Line B - Non-Sterile, Line C - Oral Solid Dosage)
[ ] In-Process Yield Percentage
[ ] Critical Process Parameters (CPP) Verified (Temperature Control, Mixing Speed/RPM, Pressure Settings, pH Levels, Granulation Time)
[ ] Batch Production Record (BPR) Scan
[ ] Production Supervisor Verification

--- POST-APPROVAL CHANGE MANAGEMENT ---
[ ] Change Control Identification Number
[ ] Change Impact Level (Minor (No impact on quality/safety), Moderate (Potential impact on validated state), Major (Significant impact on product quality/efficacy))
[ ] Description of Proposed Change
[ ] Affected Manufacturing Areas (Raw Materials, Equipment/Machinery, Analytical Methods, Packaging/Labeling, Facility/Environment)
[ ] Implementation Deadline
[ ] Risk Assessment Report
[ ] Quality Assurance Approval

--- POST-MARKET SURVEILLANCE & PHARMACOVIGILANCE ---
[ ] Adverse Event Report Date
[ ] Reported Symptom/Reaction Description
[ ] Seriousness Assessment (Serious, Non-Serious)
[ ] Associated Risk Factors (Drug-Drug Interaction, Patient Age, Dosage Error, Storage Temperature Deviation)
[ ] Causality Assessment Summary
[ ] Supporting Clinical Evidence/Lab Reports
[ ] Pharmacovigilance Officer Verification

--- SUPPLY CHAIN & DISTRIBUTION INTEGRITY ---
[ ] Distribution Shipment Date
[ ] Transport Mode (Air Freight, Road Transport, Sea Freight)
[ ] Temperature Deviation Degree (if applicable)
[ ] Distribution Integrity Checks Completed (Tamper-Evident Seal Inspection, Cold Chain Temperature Log Review, Packaging Integrity Verification, Shipping Manifest Reconciliation)
[ ] Proof of Delivery / Waybill Document
[ ] Logistics Supervisor Verification

--- PRODUCT RETIREMENT & END-OF-LIFE MANAGEMENT ---
[ ] Product Discontinuation Date
[ ] Reason for Product Retirement
[ ] Inventory Depletion & Stock Clearance Plan
[ ] Regulatory Bodies Notified (FDA, EMA, MHRA, Other National Competent Authorities)
[ ] Official Discontinuation Notice/Letter
[ ] Quality Assurance Authorization

--- END OF TEMPLATE ---
Transform this text into a digital, automated, and trackable mobile app!
Visit: https://checklistguro.com/templates/pharmaceutical/pharmaceutical-product-lifecycle-management-plm-checklist-2026
(Click "Install Template" to launch your digital inspection tool immediately)